ACM Research Announces Participation in 13th Annual NYC Summit 2024
November 29, 2024 16:05 ET | Source: ACM Research, Inc. FREMONT, Calif.,…
Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
November 18, 2024 11:15 ET | Source: BridgeBio Pharma, Inc. - Acoramidis…